Identification of nafamostat as a potent inhibitor of Middle East respiratory syndrome (MERS) corona virus S-mediated membrane fusion using the split protein-based cell-cell fusion assay
Yamamoto, Mizuki, Matsuyama, Shutoku, Li, Xiao, Takeda, Makoto, Kawaguchi, Yasushi, Inoue, Jun-ichiro, Matsuda, ZeneLanguage:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.01043-16
Date:
August, 2016
File:
PDF, 832 KB
english, 2016